Back to Search
Start Over
Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier
- Source :
- PLoS Genetics, PLoS Genetics, Public Library of Science, 2010, 6 (10), pp.e1001153. ⟨10.1371/journal.pgen.1001153⟩, PLoS Genetics, Vol 6, Iss 10 (2010)
- Publication Year :
- 2010
- Publisher :
- HAL CCSD, 2010.
-
Abstract
- Approximately 30% of alleles causing genetic disorders generate premature termination codons (PTCs), which are usually associated with severe phenotypes. However, bypassing the deleterious stop codon can lead to a mild disease outcome. Splicing at NAGNAG tandem splice sites has been reported to result in insertion or deletion (indel) of three nucleotides. We identified such a mechanism as the origin of the mild to asymptomatic phenotype observed in cystic fibrosis patients homozygous for the E831X mutation (2623G>T) in the CFTR gene. Analyses performed on nasal epithelial cell mRNA detected three distinct isoforms, a considerably more complex situation than expected for a single nucleotide substitution. Structure-function studies and in silico analyses provided the first experimental evidence of an indel of a stop codon by alternative splicing at a NAGNAG acceptor site. In addition to contributing to proteome plasticity, alternative splicing at a NAGNAG tandem site can thus remove a disease-causing UAG stop codon. This molecular study reveals a naturally occurring mechanism where the effect of either modifier genes or epigenetic factors could be suspected. This finding is of importance for genetic counseling as well as for deciding appropriate therapeutic strategies.<br />Author Summary Mild disease outcomes associated with premature termination codons can result from at least three different mechanisms, but none of these mechanisms explain the mild phenotype observed in some patients. Subtle differences in alternative transcripts have recently been reported at NAGNAG tandem acceptor motifs, which can be detected in 30% of human genes. We provide the first experimental evidence of premature termination codon removal by alternative splicing at a NAGNAG acceptor splice site. Our study emphasizes the biological significance of such alternative splicing in the context of disease-causing mutations and defines a new phenotype-modifying mechanism that buffers nonsense mutations.
- Subjects :
- Male
Cancer Research
Cystic Fibrosis
DNA Mutational Analysis
Cystic Fibrosis Transmembrane Conductance Regulator
HeLa Cell
0302 clinical medicine
HEK293 Cell
INDEL Mutation
Genetics and Genomics/Genetics of Disease
Genetics (clinical)
Genetics
Genetics and Genomics/Medical Genetics
0303 health sciences
Luminescent Protein
Genetics and Genomics/Bioinformatics
Stop codon
Pedigree
Genetics and Genomics/Gene Function
Phenotype
RNA Splice Site
030220 oncology & carcinogenesis
RNA splicing
Female
Research Article
Human
lcsh:QH426-470
Genotype
Nonsense mutation
Mutation, Missense
Biology
Transfection
DNA Mutational Analysi
03 medical and health sciences
Genetic
[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology
Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Allele
Indel
Cystic Fibrosi
Molecular Biology
Ecology, Evolution, Behavior and Systematics
030304 developmental biology
Base Sequence
Alternative splicing
Intron
Ecology, Evolution, Behavior and Systematic
lcsh:Genetics
Luminescent Proteins
Alternative Splicing
HEK293 Cells
RNA Splice Sites
HeLa Cells
Subjects
Details
- Language :
- English
- ISSN :
- 15537390 and 15537404
- Database :
- OpenAIRE
- Journal :
- PLoS Genetics, PLoS Genetics, Public Library of Science, 2010, 6 (10), pp.e1001153. ⟨10.1371/journal.pgen.1001153⟩, PLoS Genetics, Vol 6, Iss 10 (2010)
- Accession number :
- edsair.doi.dedup.....737fbc78e97c33bee0a3aa2838bf9298
- Full Text :
- https://doi.org/10.1371/journal.pgen.1001153⟩